73 articles
Medical Lead, Rare Disease at UCB discusses positive efficacy and safety results from two phase 3 studies evaluating zilucoplan, a self-administered, su...
Robert Hummel, Chief Operating Officer at Suvoda, a global clinical trial technology company, discusses the rise in trial complexity, how the focus has ...
Medical Lead, Rare Disease at UCB discusses the positive topline results from the Phase 3 RAISE trial evaluating zilucoplan, a self-administered, subcut...
Thomas Lendvay, CMO and co-founder of Tend Health, Inc. Learn more on Health Professional Radio.
Bill Stilley, is CEO and President of Adial Pharma, a company focused on developing therapies for the treatment of addiction and related diseases, speci...
Allitia DiBernardo, M.D., Vice President, Global Medical Affairs, Neuroscience, Global Commercial Strategy Organization (GCSO) at Janssen discusses a no...
For patients suffering from rare diseases, the limited number of breakthrough treatments has hindered improvements to their quality of life.
Returning guest, James Sapirstein, President and CEO of First Wave BioPharma (formerly AzurRX), a developer of targeted therapies for gastrointestinal (...
Bill Hinshaw, President and CEO of Axcella Therapeutics, discusses the initiation of a pioneering Phase 2a clinical trial in long COVID, investigating A...
Soumya Chakravarty, MD, Ph.D., Senior Director & Strategic Lead, Rheumatology Therapeutic Area, U.S. Learn more on Health Professional Radio.